<DOC>
	<DOCNO>NCT01856504</DOCNO>
	<brief_summary>To demonstrate incremental utility SSF individual undergo CCTA , expect improvement image quality diagnostic accuracy .</brief_summary>
	<brief_title>Validation Intracycle CT Motion CORrection Algorithm Diagnostic AccuracY</brief_title>
	<detailed_description>Hypothesis : Coronary CT angiography ( CCTA ) employ novel intracycle motion compensation algorithm ( SnapShot Freeze [ SSF ] ) superior CCTA without intracycle motion compensation algorithm ( `` conventional '' CCTA ) diagnostic accuracy image quality . Scientific Basis : Preliminary study ( Leipsic , Min , Journal Cardiovascular Computed Tomography [ press ] ) coronary CT angiograms individual undergo pre-procedural assessment transcatheter aortic valve replacement ( n=36 ) demonstrate improve image quality CCTA use SSF compare CCTA use SSF . Importantly , individual study receive heart rate slow agent ( e.g. , beta blocker ) , diagnostic image quality substantially improve . While statistically power per-patient basis , per-segment diagnostic accuracy CCTA use SSF superior conventional CCTA . These result complementary derive internal test GE Healthcare wherein phantom work demonstrate improved diagnostic performance use SSF compare conventional image acquisition . Long-term Goal/Purpose : To demonstrate incremental utility SSF individual undergo CCTA , expect improvement image quality diagnostic accuracy . If aim study achieve , use SSF effective temporal resolution improvement may obviate ( reduce ) need CT hardware improve temporal resolution .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Arteriosclerosis</mesh_term>
	<criteria>1 . Consenting adult patient ≥18 year age ; 2 . Suspected without know prior history CAD 3 . Not actively take heart rate lower agent least 48 hour prior study ( e.g. , AV nodal blocker beta blocker , calcium channel blocker digoxin ) 4 . Glomerular filtration rate &gt; 60 ml/min 5 . CCTA ICA within 1 week interscan event ( e.g. , myocardial infarction coronary revascularization ) 1 . Incomplete ICA CCTA ; 2 . Known CAD ( prior myocardial infarction , PCI , CABG ) 3 . Atrial Fibrillation 4 . Abnormal Renal Function ( GFR &lt; 60 ml/min ) 5 . Unwilling unable give consent 6 . Noncardiac illness life expectancy &lt; 1 year 7 . Concomitant participation another clinical trial subject subject investigational drug device 8 . Pregnant woman 9 . Allergy iodinate contrast agent 10 . Contraindications nitroglycerin 11 . Systolic blood pressure ≤90 mm Hg 12 . Contraindications β blocker nitroglycerin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Heart Disease</keyword>
	<keyword>Coronary Artery Disease</keyword>
	<keyword>Coronary Arteriosclerosis</keyword>
</DOC>